PDMR/Director Dealings & Holding(s) in Company

RNS Number : 9517J
EKF Diagnostics Holdings PLC
03 May 2022
 

 

EKF Diagnostics Holdings plc

("EKF" or the "Company")

 

PDMR/Director Dealings

& Holding(s) in Company

 

EKF, the AIM-listed global diagnostics business, announces that the Board of EKF has been informed that on Thursday 28 April 2022, certain funds connected to Christopher Mills, Non-executive Chairman, purchased a total of 1,275,000 ordinary shares of 1 pence each in the Company ("Ordinary Shares") at a price of 35 pence per Ordinary Share.

 

Following this transaction, Christopher Mills' total direct and indirect interest in the Company is 132,150,000 Ordinary Shares, representing approximately 29.04% of the total voting rights over the Company's issued share capital.

 

The Notification of Dealing Form required in accordance with UK MAR is set out below as is the Standard form for notification of major holdings received by EKF today.

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

Harwood Capital LLP and Harwood Capital Management (Gibraltar) Ltd, (the "Investment Managers")

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Christopher Mills is the non-executive Chairman of the issuer and Chief Executive of the Investment Managers

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

EKF Diagnostics Holdings plc

b)

 

LEI

 

 

213800DXTF3EAUK1AR05

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

 

Identification code

 

 

b)

 

Nature of the transaction

 

 

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

 

 

0.35

1,275,000

 

 

 

 

 

 

d)

 

Aggregated information

 

 

 

- Aggregated volume

N/A single transaction

 

 

- Price

 

 

 

e)

 

Date of the transaction

 

 

28 April 2022

f)

 

Place of the transaction

 

 

London Stock Exchange, AIMX

 

 

 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS(to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:

EKF DIAGNOSTICS HOLDINGS PLC

1b. Please indicate if the issuer is a non-UK issuer  (please mark with an "X" if appropriate)

Non-UK issuer

 

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify) iii:

 

3. Details of person subject to the notification obligation iv

Name

Harwood Capital Investment Management
(Gibraltar) Limited

City and country of registered office (if applicable)

Gibraltar

4. Full name of shareholder(s) (if different from 3.) v

Name

Harwood Capital LLP

North Atlantic Smaller Companies Investment Trust Plc

Oryx International Growth Fund Limited

City and country of registered office (if applicable)

London, United Kingdom

London, United Kingdom

Guernsey, Guernsey

5. Date on which the threshold was crossed or reached vi:

28/04/2022

6. Date on which issuer notified (DD/MM/YYYY):

29/04/2022

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments
(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B) vii

Resulting situation on the date on which threshold was crossed or reached

29.04

0.00

29.04

132,150,000

Position of previous notification (if

applicable)

28.76

0.00

28.76

 

       

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii

A: Voting rights attached to shares

Class/type of
shares

ISIN code (if possible)

Number of voting rights ix

% of voting rights

Direct

(DTR5.1)

Indirect

 (DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

GB0031509804

150,000

 

0.03

 

GB0031509804

96,000,000

 

21.10

 

GB0031509804

36,000,000

 

7.91

 

SUBTOTAL 8. A

132,150,000

29.04%

 

 

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

Type of financial instrument

Expiration
date
x

Exercise/
Conversion Period
xi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. B 1

 

 

 

 

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

Type of financial instrument

Expiration
date
x

Exercise/
Conversion Period
xi

Physical or cash

Settlement xii

Number of voting rights

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8.B.2

 

 

 

 

          

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii

 

Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary)
xiv

X

Name xv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Christopher Harwood Bernard Mills (Harwood Capital LLP)

0.03

 

 

Christopher Harwood Bernard Mills (North Atlantic Smaller Companies Investment Trust plc)

21.10

 

 

Christopher Harwood Bernard Mills (Oryx International Growth Fund Limited)

7.91

 

 

 

 

 

 

 

 

 

 

 

10. In case of proxy voting, please identify:

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

 

11. Additional information xvi

 

     

 

Place of completion

London Stock Exchange

Date of completion

28 April 2022

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBLGDSGXDDGDC
UK 100

Latest directors dealings